Etanterol

This classification denotes a bronchodilator with the molecular formula C18H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1597304395, chemically known as 5-amino-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-m-xylene-alpha,alpha-diol but generally known as etanterol, which bears US NIH Compound Identifier 208937. European Medicines Agency schedules Etanterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07262MIG. The term ETANTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). ETANTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etanterol under HS 29225000 and SITC 51467. As of Q4 2014, ETANTEROL remains the US FDA Preferred Term for this commodity. Etanterol bears US NLM identifiers UMLS ID C1880563 and NCI Concept Code C65553. SMILES: OC(CNC(CC1CCC(O)CC1)C)C1CC(CC(N)C1)CO.